14-day Premium Trial Subscription Try For FreeTry Free

Biotech Rally in Its Early Innings

10:17am, Tuesday, 05'th Mar 2024
Following a multiyear run of disappointment, biotech stocks and related ETFs are showing signs of life. For the past 90 days ending February 29, the widely observed Nasdaq Biotechnology Index was high

6 Factors to Bet on Wall Street: ETFs to Buy

02:01pm, Monday, 04'th Mar 2024
The Nasdaq Composite and the S&P 500 hit new all-time high Friday. However, there are chances of further rally.
The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-
Wall Street witnessed an upbeat December due to moderation in inflationary pressures, the likelihood of Fed rate cuts in 2024 and decent corporate earnings.

Time for Gilead Sciences-Heavy ETFs?

03:05pm, Tuesday, 12'th Sep 2023
Bank of America expects the Gilead Sciences to jump about 30%, as quoted on CNBC.
The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.
Shares of drugmakers Sanofi and Regeneron surged more than 6% on Mar 23 on COPD drug data.

Can Health Care Stocks Outperform Again In 2023?

06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

IBBQ: Healthcare Dashboard For December

05:00am, Sunday, 18'th Dec 2022
The pharmaceuticals/biotechnology subsector has good value and quality scores. The healthcare equipment industry is significantly overvalued.
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomic
Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in i
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.
Earlier this week, Pfizer (NYSE:PFE) announced plans to acquire Biohaven Pharmaceutical (NASDAQ:BHVN) for $11.6 billion, sparking hopes of more biotechnology consolidation activity to come. Pfizer is
After disappointing in 2021, biotechnology stocks and exchange traded funds are getting shellacked this year as growth stocks fall out of favor due to rising interest rates. As experienced biotech inv

Biotech ETFs Muddled Despite Amgen Strength

07:20pm, Tuesday, 08'th Feb 2022
Biotechnology sector-specific exchange traded funds were flat after Amgen (NasdaqGS: AMGN) provided a mixed earnings report but announced that it will return value to investors through greater share b
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE